Literature DB >> 30040455

Uncommon Types of Lung Carcinoma With Mixed Histology: Sarcomatoid Carcinoma, Adenosquamous Carcinoma, and Mucoepidermoid Carcinoma.

Alain C Borczuk1.   

Abstract

CONTEXT: - Lung tumors are histologically heterogeneous, but classification of lung carcinoma has prognostic impact and increasingly, specific molecular correlates.
OBJECTIVE: - To update the gross, microscopic, and molecular pathology of unusual lung carcinomas to assure accurate classification. In entities with mixed histology, the recognition of specific features or rare patterns is critical to diagnosis. These diagnoses can identify tumors with aggressive clinical behavior, and diagnostic pitfalls can therefore result in underdiagnosis of these already rare entities. Incorrect classification of more indolent tumors into the more aggressive categories can also occur. In the area of molecular pathology, these unusual tumors have a specific spectrum of molecular alterations. DATA SOURCES: - PubMed searches for lung and sarcomatoid carcinoma, pleomorphic carcinoma, blastoma, carcinosarcoma, and adenosquamous and mucoepidermoid carcinoma were undertaken and this information was integrated with clinical experience of the author.
CONCLUSIONS: - These uncommon carcinomas have specific clinicopathologic features, and attention to their gross and microscopic pathology leads to classification with important associated molecular findings.

Entities:  

Mesh:

Year:  2018        PMID: 30040455     DOI: 10.5858/arpa.2017-0584-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  An Uncommon Lung Neoplasm in a Young Patient: Diagnostic Challenges.

Authors:  Felipe Saceanu Leser; Lucas Dalsenter Romano; Kauê Ruan de Resende; José Roberto Lapa E Silva
Journal:  Am J Case Rep       Date:  2020-10-16

2.  Dyspnea, focal wheeze, and a slow growing endobronchial tumor.

Authors:  Melanie Chin; Ashish Gupta; Marcio M Gomes; Donna Maziak; Sunita Mulpuru
Journal:  Respir Med Case Rep       Date:  2021-01-30

3.  Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous Histology.

Authors:  Tejas Patil; Yunan Nie; Dara L Aisner; David Ross Camidge
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

4.  Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.

Authors:  Greta Alì; Rossella Bruno; Anello Marcello Poma; Ornella Affinito; Antonella Monticelli; Paolo Piaggi; Sara Ricciardi; Marco Lucchi; Franca Melfi; Antonio Chella; Sergio Cocozza; Gabriella Fontanini
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

5.  The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics.

Authors:  Ming Tang; Hussein A Abbas; Marcelo V Negrao; Maheshwari Ramineni; Xin Hu; Shawna Marie Hubert; Junya Fujimoto; Alexandre Reuben; Susan Varghese; Jianhua Zhang; Jun Li; Chi-Wan Chow; Xizeng Mao; Xingzhi Song; Won-Chul Lee; Jia Wu; Latasha Little; Curtis Gumbs; Carmen Behrens; Cesar Moran; Annikka Weissferdt; J Jack Lee; Boris Sepesi; Stephen Swisher; Chao Cheng; Jonathan Kurie; Don Gibbons; John V Heymach; Ignacio I Wistuba; P Andrew Futreal; Neda Kalhor; Jianjun Zhang
Journal:  Nat Commun       Date:  2021-12-06       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.